^
BIOMARKER:

NFE2L2 mutation

i
Other names: NFE2L2, Nuclear Factor Erythroid 2 Like 2, Nuclear Factor Erythroid 2-Related Factor 2, NF-E2-Related Factor 2, HEBP1, Nrf-2, NRF2, Nuclear Factor Erythroid Derived 2 Like 2, Nuclear Factor (Erythroid-Derived 2)-Like 2, Nuclear Factor Erythroid-Derived 2-Like 2, Nuclear Factor Erythroid 2-Like 2, NFE2-Related Factor 2, IMDDHH
Entrez ID:
Related biomarkers:
NFE2L2 mutation
NSCLC
DRP-104
Sensitive: B - Late Trials
NFE2L2 mutation
Lung Non-Small Cell Squamous Cancer
CB-228
Sensitive: C2 – Inclusion Criteria
NFE2L2 mutation
NSCLC
Immunotherapy
Resistant: C3 – Early Trials
NFE2L2 mutation
Solid Tumor
IPN60090
Sensitive: C3 – Early Trials
NFE2L2 mutation
Lung Cancer
IPN60090
Sensitive: D – Preclinical